pax8 ppar fusion protein in thyroid carcinoma
play

PAX8-PPAR Fusion Protein in thyroid carcinoma Ronald J. Koenig, - PowerPoint PPT Presentation

Sidney H. Ingbar Lecture, ATA 10/17/2013: PAX8-PPAR Fusion Protein in thyroid carcinoma Ronald J. Koenig, MD, PhD Division of Metabolism, Endocrinology & Diabetes University of Michigan PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE


  1. Sidney H. Ingbar Lecture, ATA 10/17/2013: PAX8-PPAR γ Fusion Protein in thyroid carcinoma Ronald J. Koenig, MD, PhD Division of Metabolism, Endocrinology & Diabetes University of Michigan PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  2. Learning Objectives  1. Know what the PAX8-PPAR  Fusion Protein is.  2. Know what types of thyroid cancer are associated with the PAX8-PPAR  Fusion Protein.  3. Know about a clinical trial specifically designed for patients with PAX8-PPAR  Fusion Protein thyroid cancer.  4. Know the normal function of PPAR  .  5 Know about the Wnt pathway. (No disclosures) PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  3. Outline of today’s presentation  Background  PPFP carcinoma patient samples  Mouse model of PPFP thyroid carcinoma  PPFP cell lines  Summary and conclusions PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  4. Gene mutations underlie thyroid carcinoma Vu-Phan D & Koenig RJ. Mol. Cell. Endocrinol., in press (review) PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  5. PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  6. PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  7. PPFP is generated by a chromosomal translocation Paired Box Gene 8 ( PAX8 ): Chr 2q13 1 2 3 4 5 6 7 8 9 10 11 12 Translocation (2;3)(q13;p25) 1 2 3 4 5 6 Peroxisome Proliferator-Activated Receptor Gamma ( PPARG ): Chr 3p25 DBD DBD LBD Fusion junction PPAR  PAX8 PAX8-PPAR  Fusion Protein (PPFP) PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  8. Functions of PAX8 and PPAR  .  PAX8 is a transcription factor that is essential for thyroid development and that drives the expression of many thyroid-specific genes.  PPAR  is the master regulator of adipogenesis , among other functions.  PPAR  is expressed at very low levels in normal thyroid and has no known function in that organ. PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  9. PAX8-PPAR  has dominant negative activity over PPAR  (transfections in U2OS osteosarcoma cells) Kroll TG, et al . Science 289:1357-60, 2000 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  10. PPAR  , a putative tumor suppressor  Several mouse models of cancer are exacerbated by a single allele deletion of Pparg , including a model of thyroid cancer that is unrelated to PPFP (Kato, et al . Oncogene 25:2736, 2006).  Hypothesis : PPFP is oncogenic because it inhibits the tumor suppressor activity of PPAR  . PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  11. Outline of today’s presentation  Background  PPFP carcinoma patient samples  Mouse model of PPFP thyroid carcinoma  PPFP cell lines  Summary and conclusions PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  12. Gene expression signature of PPFP follicular thyroid cancers Thomas Giordano, MD, PhD FC(+) FC(-) NT FA OA OC PC AC MC Giordano TG, et al . Clin Cancer Res. 12:1983-93, 2006 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  13. Gene expression signature of PPFP follicular thyroid cancers. FC(+) FC(-) NT FA OA OC PC AC MC AQP7 ANGPTL4 Giordano TG, et al . Clin Cancer Res. 12:1983-93, 2006. PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  14. PPFP has PPAR  -like activity on the AQP7 promoter. AQP7-Luc -Cz +Cz 20 6 JEG-3 N2a 5 16 4 12 3 8 2 4 1 Fold Activity Luc/Rluc 0 0 6 60 FRTL-5 Dog thyrocytes 5 50 4 40 3 30 2 20 1 10 0 0 PPAR  PPAR  pCDNA PAX8 PPFP pCDNA PAX8 PPFP Giordano TG, et al . Clin Cancer Res. 12:1983-93, 2006. PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  15. Outline of today’s presentation  Background  PPFP carcinoma patient samples  Mouse model of PPFP thyroid carcinoma  PPFP cell lines  Summary and conclusions PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  16. Thyroidal expression of PPFP in transgenic mice Melissa Dobson, PhD Ericka Diallo-Krou CAG promoter PPFP eGFP intron Lox P Lox P X TPO promoter Cre Dobson ME, et al . Endocrinology. 152:4455-65, 2011 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  17. Thyroidal expression of PPFP in transgenic mice CAG promoter PPFP eGFP intron Lox P Lox P X TPO promoter Cre 40 Wild type PPFP;Cre PPFP/PPAR  30 20 10 Hyperplasia, 0 PPFP;Cre No neoplasia mean±SD, n=14 Dobson ME, et al . Endocrinology. 152:4455-65, 2011 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  18. FTC pAKT PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  19. FTC pAKT PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  20. PPFP carcinomas have increased phosphoAKT pAKT(S473) Immunohistochemistry Normal human thyroid PPFP cancer Diallo-Krou E, et al . Endocrinology. 150:5181-90, 2009 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  21. PPFP carcinomas have increased phosphoAKT pAKT(S473) Immunohistochemistry Normal human thyroid PPFP cancer Combined PPFP expression with thyroid- Mouse Thyroid AKT immunoblot specific Pten deletion: PPFP;PtenFF;Cre Control mice Pten deletion: PtenFF;Cre. pAKT(T308) pAKT(S473) Total AKT  -actin PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  22. Mouse thyroid glands Wild type PtenFF;Cre PPFP;PtenFF;Cre Dobson ME, et al . Endocrinology. 152:4455-65, 2011 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  23. PPFP;PtenFF;Cre mice develop metastatic thyroid carcinoma Tracheal Invasion Vascular Invasion H&E Myc (PPFP) TTF-1 Lung Metastases H&E Myc (PPFP) TTF-1 PAX8 (PtenFF;Cre mice have benign thyroid hyperplasia with no neoplasia). Dobson ME, et al . Endocrinology. 152:4455-65, 2011 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  24. Pioglitazone therapy of PPFP;PtenFF;Cre thyroid cancer Thyroid size by ultrasound PPFP;PtenFF;Cre PtenFF;Cre Control Diet Pioglitazone 120- 110- Thyroid Area (mm 2 ) 100- 90- 18- 80- 16- 70- 14- 60- 12- 50- 10- 40- 8- 30- 6- 20- 4- 10- 2- 0- Start End 0- Start End WT thyroid area 1.9±0.5 mm 2 Dobson ME, et al . Endocrinology. 152:4455-65, 2011 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  25. Pioglitazone therapy of PPFP;PtenFF;Cre thyroid cancer. Thyroid size by ultrasound Pioglitazone prevents local invasion and PPFP;PtenFF;Cre PtenFF;Cre metastases in PPFP;PtenFF;Cre mice Control Diet Pioglitazone 120- Local Vascular Distant 110- N invasion invasion mets Thyroid Area (mm 2 ) 100- 90- 18- Control diet 12 11 5 7 80- 16- 70- 14- Pioglitazone 10 1 0 0 60- 12- 50- 10- P 0.0002 0.03 0.005 40- 8- 30- 6- (Neither invasion nor metastases were 20- 4- 10- 2- found in any PtenFF;Cre mice) 0- Start End 0- Start End WT thyroid area 1.9±0.5 mm 2 Dobson ME, et al . Endocrinology. 152:4455-65, 2011. PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  26. Adipogenic PPAR  -like response to pioglitazone in PPFP;PtenFF;Cre thyroids Control Diet Pioglitazone PtenFF;Cre PtenFF;Cre PPFP; Lipid droplets 100  Dobson ME, et al . Endocrinology. 152:4455-65, 2011 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

  27. Adipogenic PPAR  -like response to pioglitazone in PPFP;PtenFF;Cre thyroids Control Diet Pioglitazone PPFP;PtenFF;Cre +Pio PtenFF;Cre Oil Red O Perilipin-1 PtenFF;Cre PPFP; Lipid droplets 100  Dobson ME, et al . Endocrinology. 152:4455-65, 2011 PRESENTATION FROM THE 83rd ANNUAL MEETING OF THE AMERICAN THYROID ASSOCIATION, OCTOBER 16-20, 2013 (Ronald J. Koenig)

Recommend


More recommend